Genzyme will host a comprehensive FOUNDATION fieldbus-seminar on Nov. 3-4 in Cambridge, MA. The event will include hands-on instruction in the use of FOUNDATION fieldbus control-systems and feature presentations by fieldbus technology experts.
At Genzyme, Tri-State University Technology Center will host a workshop covering fieldbus end-user applications in the pharmaceutical and biomedical industries. The workshop will describe implementation of the open, integrated FOUNDATION fieldbus H1 and High Speed Ethernet (HSE) automation architecture in life-sciences production environments.
Thursday’s activities will also include an optional tour of Genzyme’s Allston Landing manufacturing facility, which includes several hundred FOUNDATION fieldbus nodes. The 180,000-square-foot facility has bulk manufacturing capacity for multiple products utilizing recombinant mammalian-cell culture.
Included is an overview of the Fieldbus Foundation’s global End User Councils (EUCs), presentations concerning Electronic Device Description Language (EDDL) technology and fieldbus economic models, and an update on recent FF activities worldwide. Prominent end-user companies will also give presentations.
To register for the Cambridge seminar, click here .
— Richard Phelps, senior editor, Control Engineering
[email protected]
